Boston Scientific Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2005 — Data Talk
Boston Scientific Corporation (BSX) is currently at $97.33, down $0.90 or 0.92%
--Would be lowest close since April 22, 2025, when it closed at $95.05
--Currently down 11 of the past 12 days
--Currently down nine consecutive days; down 10% over this period
--Longest losing streak since Sept. 21, 2005, when it fell for nine straight trading days
--Worst nine day stretch since the nine days ending April 8, 2025, when it fell 11.43%
--Down 5.24% this week; worst weekly performance since the week ending April 4, 2025, when it fell 9.72%
--Down 7.74% month-to-date
--Up 8.97% year-to-date
--Down 10% from its all-time closing high of $108.14 on Sept. 8, 2025
--Up 15.98% from 52 weeks ago (Sept. 20, 2024), when it closed at $83.92
--Down 10% from its 52-week closing high of $108.14 on Sept. 8, 2025
--Up 17.15% from its 52-week closing low of $83.08 on Sept. 26, 2024
--Traded as low as $97.26
--Down 0.99% at today's intraday low
All data as of 10:48:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 19, 2025 11:07 ET (15:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
2 Undervalued Stocks to Buy Before They Rebound
